Late Night Market Recap

 Night.Owl
 
  Night.Owl
 
Follow  Message
 
 
 
Night.Owl masters market recaps, offering sharp analysis that uncovers hidden patterns and key moves. Stay ahead with Night.Owl’s expert insights.
 

•  10 Dec 2025
 

•   ADBE  
   
  +3.88%
•   AVGO  
   
  -12.84%
•   BYND  
   
  -11.38%
•   CHWY  
   
  -7.44%
•   CPRT  
   
  -1.33%

$INTC Intel continued to command attention as shares climbed on heavy volume, backed by catalysts including its role in Europe deep-tech scale-up program, a potential acquisition of AI chip startup SambaNova Systems, and its strongest annual performance since 1996. The stock also picked up an upgrade from KGI Securities as analysts reassessed Intel’s competitive positioning in a rapidly evolving semiconductor market.

$BYND Beyond Meat moved sharply as traders weighed bargain-hunting spikes against a long-running decline that has erased roughly 99% of its value over five years. Despite a temporary 10% rebound earlier this week, concerns over profitability and slowing revenue remain dominant, leaving BYND mostly in speculative territory during late-night trading.

$AVGO supported by strong AI chip demand, private-cloud expansion for small businesses, and expectations for another record quarter. With the stock already up 74% in 2025, valuation debates intensified while traders focused on whether Broadcom can deliver results strong enough to extend the rally.

$CHWY Chewy reversing early weakness after Q3 results topped expectations on revenue, EPS, and customer growth. Shares rose as much as traders highlighted accelerating loyalty metrics and improving operating leverage, though management’s softer Q4 outlook kept volatility elevated.

$XOM Exxon Mobil advanced after projecting an additional $5 billion in earnings growth by 2030 without relying on higher oil prices. A wave of analyst upgrades and supportive factor-based models added momentum, keeping XOM in favor among traders seeking durable cash-flow and double-digit upside potential.

$GME GameStop extended losses following a disappointing Q3 release that underscored continued operational challenges. Despite incremental improvements in certain business lines, the stock fell more than 4% as traders reassessed the probability of a sustainable turnaround.

$CVS CVS Health ticked higher after raising its 2025 revenue outlook and receiving multiple bullish analyst reiterations. With shares still trading at an attractive valuation and momentum improving across its healthcare platform, traders positioned CVS as a steady compounder heading into 2026.

$CPRT Copart remained active in late-night discussion after several insider option-exercise disclosures hit the tape. While the filings showed no immediate monetary gain, the clustering of insider activity prompted traders to watch for strategic signals, keeping CPRT in focus despite limited price reaction.

$CVX Chevron outperformed as energy names strengthened, supported by its newly announced 2026 capital budget and a 4.6% yield that continues to attract income-oriented traders. With the stock trading at compelling multiples, CVX held its position as a high-conviction pick amid macro uncertainty.

$MO Altria inched higher after declaring its $1.06 dividend while continuing to navigate persistent volume declines. The stock’s discounted valuation and stable cash-return profile kept MO appealing for late-night traders prioritizing yield over growth.

$ADBE Adobe slipped slightly despite delivering strong Q4 results, including 10% revenue growth and better-than-expected EPS. Its new integrations with ChatGPT and expanding AI-driven product suite captured attention, but valuation friction led to a muted reaction. Traders framed ADBE as a core long-term AI software name consolidating after an extended run.

View All Headlines